https://orcid.org/0000-0003-4032-2744
References
- Abelson MB, Smith L, Chapin M. Ocular allergic disease: mechanisms, disease sub-types, treatment. Ocul Surf 2003; 1: 127–149.
- La Rosa M, Lionetti E, Reibaldi M, et al. Allergic conjunctivitis: a comprehensive review of the literature. Ital J Pediatr 2013; 39: 18–25.
- Graziano FM, Stahl JL, Cook EB, et al. Conjunctival mast cells in ocular allergic disease. Allergy Asthma Proc 2001; 22: 121–126.
- Abelson MB, Mclaughlin JT, Gomes PJ. Antihistamines in ocular allergy: are they all created equal? Curr Allergy Asthma Rep 2011; 11: 205–211.
- Greiner J V, Udell IJ. A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model. Clin Ther 2005; 27: 568–577.
- Kimchi N, Bielory L. The allergic eye: recommendations about pharmacotherapy and recent therapeutic agents. Curr Opin Allergy Clin Immunol 2020; 20: 414–420.
- Bielory L, Delgado L, Katelaris CH, et al. Special Series ICON Diagnosis and management of allergic conjunctivitis. 2020. doi:10.1016/j.anai.2019.11.014
- Asiedu K, Kyei S, Mensah SN, et al. Ocular Surface Disease Index (OSDI) versus the Standard Patient Evaluation of Eye Dryness (SPEED): a Study of a Nonclinical Sample. Cornea 2016; 35: 175–180.
- Pucker AD, Dougherty BE, Jones-Jordan LA, et al. Psychometric Analysis of the SPEED Questionnaire and CLDEQ-8. Invest Ophthalmol Visual Sci 2018; 59: 3307–3313.
- Papas EB, Keay L, Golebiowski B. Estimating a just-noticeable difference for ocular comfort in contact lens wearers. Invest Ophthalmol Vis Sci 2011; 52: 4390–4394.
- Sullivan BD, Crews LA, Sönmez B, et al. Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management. Cornea 2012;31:1000–1008.
- Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform 2019;95:103208.
- Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377–381.
- Pucker AD, McGwin G, Franklin QX, et al. Application of systane complete for the treatment of contact lens discomfort. Cont Lens Anterior Eye 2020; 101399. DOI:10.1016/j.clae.2020.12.004
- Artal MN, Luna JD, Discepola M. A forced choice comfort study of olopatadine hydrochloride 0.1% versus ketotifen fumarate 0.05%. Acta Ophthalmol Scand Suppl 2000; 78: 64–65.
- Leonardi A, Zafirakis P. Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: a double-masked, environmental study of patient preference. Curr Med Res Opin 2004; 20: 1167–1173.
- Aguilar AJ. Comparative study of clinical efficacy and tolerance in seasonal allergic conjunctivitis management with 0.1% olopatadine hydrochloride versus 0.05 ketotifen fumarate. Acta Ophthalmol Scand Suppl 2000; 78: 52–55.
- Pult H, Murphy PJ, Purslow C, et al. Limbal and bulbar hyperaemia in normal eyes. Ophthalmic Physiol Opt 2008; 28: 13–20.
- Greiner J V, Minno G. A placebo-controlled comparison of ketotifen fumarate and nedocromil sodium ophthalmic solutions for the prevention of ocular itching with the conjunctival allergen challenge model. Clin Ther 2003; 25: 1988–2005.